What Is SBP-Tag? Definition and What Research Reports
SBP-tag (streptavidin-binding peptide tag) is a short engineered peptide sequence that binds streptavidin with nanomolar affinity and is fused to recombinant proteins so they can be captured and purified in a single step. It is a laboratory reagent, not a therapeutic peptide. Published work reported one-step purification of tagged proteins, a crystal structure of the peptide bound to streptavidin, and single-step isolation of intact protein complexes such as condensin and ERK signalling assemblies.
Plain definition
SBP-tag is short for streptavidin-binding peptide tag: a small, engineered peptide sequence that is genetically fused to a protein of interest so that the resulting fusion protein can be captured on streptavidin-based resin and recovered from a complex mixture. In the primary description of the reagent, researchers characterised it as a nanomolar-affinity streptavidin-binding peptide that permitted one-step purification of recombinant proteins (PMID 11722181). The term therefore refers to a molecular-biology tool — a handle attached to other proteins — rather than to a compound that is administered to an organism for a physiological effect. This page is for educational purposes only and is not medical advice; consult a licensed physician for any health or treatment questions.
What class of molecule is it?
The SBP-tag belongs to the class of affinity tags: short peptide or protein sequences appended to a recombinant protein's coding sequence so that the expressed product carries a built-in binding site for a known partner. Within that class, SBP-tag is a peptide tag rather than a protein domain tag, meaning it is a short amino-acid stretch rather than a folded enzyme or binding protein. Its binding partner is streptavidin, the bacterial biotin-binding protein widely used in laboratory capture chemistry.
In the vocabulary used across peptide science, SBP-tag sits alongside other sequence tags used in expression and purification workflows. It is not a hormone analogue, a secretagogue, or any other class of bioactive peptide studied for physiological effects in animals or humans. None of the verified literature summarised here describes administration of SBP-tag to a living subject.
Where the term comes from
The name is descriptive: the tag is a peptide (P) that binds streptavidin (SB). Unlike peptides isolated from tissue, the SBP-tag is a laboratory-derived sequence — it was developed and characterised specifically as a purification reagent, and the 2001 report introducing it described the sequence as a streptavidin-binding peptide with nanomolar affinity used for one-step recovery of recombinant proteins (PMID 11722181). Because streptavidin resin and streptavidin-conjugated detection reagents were already standard laboratory materials, a peptide that binds streptavidin directly gave researchers a way to use that existing infrastructure without biotinylating the target protein enzymatically or chemically.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeHow the term is used in research writing
In published methods sections, "SBP-tag" usually appears in one of a few recurring constructions:
- As a fusion descriptor — for example, "SBP-tagged SMC2", indicating that the tag sequence was fused to the named protein at the DNA level before expression (PMID 21194474).
- As a purification strategy — describing single-step affinity capture of a tagged protein or of the larger assembly it belongs to (PMID 27924562).
- As a detection handle — the same streptavidin interaction that supports capture also supports labelled-streptavidin detection, and one study reported that an SBP-tagged subunit allowed affinity fluorescence and blotting in addition to purification (PMID 21194474).
- As a structural subject — in work where the peptide itself, rather than its cargo, is the object of study (PMID 23633599).
Readers encountering the term in a peptide context should note that it almost always signals a protein-engineering or proteomics paper rather than a pharmacology paper.
What the published literature reports
Original characterisation
The introducing report described the SBP-tag as a streptavidin-binding peptide with nanomolar affinity and demonstrated its use for one-step purification of recombinant proteins (PMID 11722181). The framing in that title — "one-step purification" — is the property most often cited when later papers explain why they chose the tag: capture and recovery occur in a single chromatographic operation rather than a multi-column sequence.
Structural basis of binding
A later crystallographic study reported the structure of the SBP-tag–streptavidin complex and described a novel helical scaffold that bridged binding pockets located on separate streptavidin subunits (PMID 23633599). That finding is notable because it indicated the peptide does not simply occupy a single biotin site; the study reported an interaction spanning more than one subunit of the tetrameric protein (PMID 23633599).
Use with multi-protein complexes
Two application papers in the verified set illustrate how the tag has been used when the goal was an intact assembly rather than a single polypeptide. In one, researchers reported that SBP-tagging the condensin subunit SMC2 allowed single-step affinity fluorescence, blotting or purification of the condensin complex (PMID 21194474). In a methods chapter, researchers described single-step affinity purification of ERK signalling complexes using the streptavidin-binding peptide tag (PMID 27924562). In both cases the reported use was isolation of a tagged bait together with its associated partners.
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appQuick reference
| Question | What the verified literature supports |
|---|---|
| Molecule class | Engineered peptide affinity tag that binds streptavidin (PMID 11722181) |
| Binding partner | Streptavidin; the structure reported a helical scaffold bridging pockets on separate subunits (PMID 23633599) |
| Reported affinity | Described as nanomolar in the original report (PMID 11722181) |
| Typical reported application | One-step purification of recombinant proteins (PMID 11722181) and of protein complexes (PMID 27924562) |
| Non-purification use reported | Affinity fluorescence and blotting with a tagged subunit (PMID 21194474) |
| Human administration data in this set | None |
Safety and Adverse Events: What Studies Report
The verified literature collected for this entry consists of protein-biochemistry and methods papers: an original purification reagent report (PMID 11722181), a crystallographic structure (PMID 23633599), and two complex-purification applications (PMID 21194474, PMID 27924562). None of these reported administration to animals or humans, and none reported doses, exposure durations, or adverse events in a living subject. Any statement about safety in people would therefore go beyond what this body of work examined.
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeCommon points of confusion
- SBP-tag is not biotin. The tag is a peptide sequence that binds streptavidin; it is not a vitamin, and the reported binding interface was described crystallographically as a helical scaffold spanning binding pockets on separate streptavidin subunits (PMID 23633599).
- SBP-tag is not a research peptide in the pharmacological sense. The published uses in this set were laboratory capture, detection and structural characterisation, not physiological intervention.
- "Single-step" refers to chromatography, not to speed of an outcome. The phrase in these titles described purification performed in one affinity step (PMID 27924562).
Scope of this entry
This is a definitional reference entry. It summarises how the term is defined and what the four cited papers reported; it does not describe protocols, buffer conditions, resin choices, or comparisons with other affinity tags beyond what those papers stated in scope. Readers following the literature further will find a much broader methods ecosystem around streptavidin-based capture than the sources summarised here.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeReferences
- One-step purification of recombinant proteins using a nanomolar-affinity streptavidin-binding peptide, the SBP-Tag (Protein Expression and Purification, 2001)
- Streptavidin-Binding Peptide (SBP)-tagged SMC2 allows single-step affinity fluorescence, blotting or purification of the condensin complex (BMC Biochemistry, 2010)
- The structure of the SBP-Tag-streptavidin complex reveals a novel helical scaffold bridging binding pockets on separate subunits (Acta Crystallographica Section D: Biological Crystallography, 2013)
- Single-Step Affinity Purification of ERK Signaling Complexes Using the Streptavidin-Binding Peptide (SBP) Tag (Methods in Molecular Biology, 2017)
Frequently asked questions
What does SBP-tag stand for?▾
SBP-tag stands for streptavidin-binding peptide tag. It is a short engineered peptide sequence fused to a recombinant protein so the protein can be captured on streptavidin-based material. The original report described it as a nanomolar-affinity streptavidin-binding peptide used for one-step purification of recombinant proteins (PMID 11722181). The name describes the binding partner, not a biological activity in an organism.
Is SBP-tag a therapeutic peptide?▾
No. In the literature summarised here, SBP-tag functions as a laboratory affinity reagent rather than a compound studied for physiological effects. The cited papers covered one-step protein purification (PMID 11722181), a crystal structure of the peptide bound to streptavidin (PMID 23633599), and purification of protein complexes (PMID 27924562). None reported administration to animals or humans.
What did structural work report about how SBP-tag binds streptavidin?▾
A crystallographic study reported the structure of the SBP-tag–streptavidin complex and described a novel helical scaffold that bridged binding pockets on separate streptavidin subunits (PMID 23633599). That result indicated the interaction was not confined to a single subunit pocket of the tetrameric protein, which researchers presented as a distinguishing structural feature of this peptide.
Why do researchers describe SBP-tag purification as "one-step"?▾
The phrase refers to capturing and recovering a tagged protein in a single affinity chromatography operation rather than a series of columns. The introducing report framed the tag around one-step purification of recombinant proteins (PMID 11722181), and a later methods chapter described single-step affinity purification of ERK signalling complexes using the SBP tag (PMID 27924562).
Has SBP-tag been used for anything besides purification?▾
Yes. In one study, researchers reported that SBP-tagged SMC2 allowed single-step affinity fluorescence, blotting or purification of the condensin complex (PMID 21194474). Because the tag binds streptavidin, the same interaction that supports capture on resin can also support detection with labelled streptavidin reagents, as that report described.
Can SBP-tag be used to isolate whole protein complexes?▾
The published applications suggest that was a common goal. One study reported recovery of the condensin complex through an SBP-tagged SMC2 subunit (PMID 21194474), and a methods chapter described single-step affinity purification of ERK signalling complexes with the SBP tag (PMID 27924562). In both cases the tagged protein served as bait for its associated partners.
Does the cited literature report any doses or side effects for SBP-tag?▾
No. The four papers summarised here are protein-biochemistry and methods reports covering purification (PMID 11722181), structure (PMID 23633599), and complex isolation (PMID 21194474, PMID 27924562). None reported dosing, exposure duration, or adverse events in a living subject. This page is educational only and is not medical advice.
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.